Sunil Abhyankar - Concepedia

Author

Sunil Abhyankar

University of Kansas Medical Center ORCID

Also Known As

S Abhyankar, S H Abhyankar, S. Abhyankar, S. H. Abhyankar, S.H. Abhyankar, SUNIL ABHYANKAR, Sunil Abhyankar, Sunil H Abhyankar, Sunil H. Abhyankar, Sunil Hari Abhyankar

339

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center University of Kansas The University of Kansas Cancer Center Dana-Farber Cancer Institute Medical College of Wisconsin

About

Sunil Abhyankar is an author at University of Kansas Medical Center specializing in medicine, transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.8K
2	Biomedical Engineering	3	3	157
3	Health Sciences	2	2	100
4	Public Health	2	2	76
5	Engineering	1	1	14

Sunil Abhyankar

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, The Lancet Oncology Cutaneous T-cell LymphomaLymphoid NeoplasiaMedicinePathologyMogamulizumab Versus Vorinostat	2018	621
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study Corey Cutler, Stephanie J. Lee, Sally Arai, Blood	2021	295
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203) Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser, The Lancet Haematology Versus TacrolimusTransplantationImmunosuppressive TherapyImmunologyHematology	2019	274
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation Adriana Bastidas, Javier de la Serna, Mohamed El Idrissi, JAMA	2019	244
Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant P. Jean Henslee‐Downey, Sunil Abhyankar, Rudolph S. Parrish, Blood	1997	213
Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease Sunil Abhyankar, S Neben, G W Newman, Blood	1991	175
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1 Ramesh Balusu, Warren Fiskus, Rekha Rao, Blood	2011	134
INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT VERSUS HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS1 Sunil Abhyankar, D. Gary Gilliland, James L.M. Ferrara Transplantation	1993	128
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Blood	2007	123
Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease1 Kuang‐Yueh Chiang, Sunil Abhyankar, Kerry D. Bridges, Transplantation	2002	111

Page 1